StockVS

NYSE · Health Information Services · USD

Hinge Health, Inc. (HNGE) Stock Analysis

Hinge Health, Inc. (HNGE) is a Health Information Services stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

HNGE

$112.00

+$4.49 (+4.18%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HNGE with… →

HNGE Key Statistics

As of Oct 21, 2026
Trading
Open
$108.16
Previous Close
$107.51
Day's Range
107.82–112.24
52-Week Range
30.08–112.24
Volume
2.74M
Valuation
Market Cap
$9.04B
P/E Ratio
36.96
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
36.63
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
12.55
EPS (ttm)Profit attributable to each share over the last twelve months.
3.03
Financials (FY)
Revenue (FY)
$587.86M+50.58%
Net Income (FY)
−$528.26M
Profit marginThe share of revenue left as profit after all costs and taxes.
15.15%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
62.47M
1-Year Return
+125.17%
Dividend and dates
Earnings Date
November 2, 2026
Avg Volume
1.83M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, HNGE closed at $112.00, +125.17% over 1 year.

Hinge Health, Inc. (HNGE) has a market capitalization of $9.04B.

In fiscal 2025, HNGE reported revenue of $587.86M.

HNGE Stock Return by Calendar Year

Hinge Health, Inc. (HNGE) return since May 2025: what $10,000 became

1 year
$10,000 $22,517
+125.17%
Since May 2025
$10,000 $29,819
+198.19%

If you had invested $10,000 in Hinge Health, Inc. (HNGE) at the close on May 22, 2025, the earliest close on record here, it would have been worth $29,819 at the close on October 21, 2026: +198.19% in total, +116.38% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+141.12%
2025 (partial year)+23.67%

As of October 21, 2026.

HNGE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$587.86M−$528.26M−89.9%
2024$390.40M−$11.93M−3.1%
2023$292.73M−$108.14M−36.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$587.86M$468.22M−$546.37M−$528.26M−89.9%
2024$390.40M$299.90M−$31.91M−$11.93M−3.1%
2023$292.73M$194.18M−$130.51M−$108.14M−36.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HNGE Valuation vs Health Information Services Median

Median of 44 stocks
MetricHNGEHealth Information Services medianvs median
P/E36.9646.5421% below
P/S ratio12.552.315.4x the median
Profit margin15.15%−7.55%22.7 pts above

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Hinge Health, Inc. (HNGE) is capitalised at $9.04B on the latest close. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 1,437 employees.

The most recent close on file for HNGE is $112.00, dated October 21, 2026. That is +$4.49 (+4.18%) against the previous close. Over the past 52 weeks the price has ranged from $30.08 to $112.24. The latest close sits 272.34% above that 52-week low.

Financial Health

In fiscal 2025, Hinge Health, Inc. reported revenue of $587.86M. That is +50.58% against the prior fiscal year, when revenue was $390.40M. The same year closed with a net loss of $528.26M. The reported profit margin is 15.15%. That is 22.7 percentage points above the Health Information Services median of −7.55%. Earnings per share on a trailing basis come to 3.03.

Across the 3 fiscal years on file, revenue moves from $292.73M in 2023 to $587.86M in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 36.96. That is 20.58% below the Health Information Services median of 46.54. On forward earnings the ratio is 36.63. Measured against sales, the shares trade at 12.55 times revenue. On price-to-sales that is 5.4 times the Health Information Services median of 2.31. The medians here are taken across 44 Health Information Services companies that report the metric.

Over the trailing twelve months the total return is +125.17%. Annualized volatility over the trailing 1 year is 53.66%.

Growth & Income

The record shows no dividend for HNGE.

2026 is still running; the total return is +141.12% year to date.

Peer Comparison

Hinge Health, Inc. (HNGE) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Hinge Health, Inc. HNGE $9.04B 37.0
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. Hinge Health, Inc. trades at a P/E of 37.0.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Visit website →